The analysis revealed significant enrichment in several pathways for the upregulated genes, with the mitogen-activated protein kinase (MAPK) pathway being particularly prominent (Figures S1B and S1C), suggesting it as a potential key pathway in EB’s anti-pancreatic cancer activity. This evidence concerns the gene WNK2 and familial pancreatic carcinoma.